role of eicosanoids but not nitric oxide in the platelet-activating factor-induced increase in vascular permeability in mouse skin

By Fujii E.   Irie K.   Uchida Y.   Ohba K.   Muraki T.  

European Journal of Pharmacology, Vol. 273, Iss. 3, 1995-02 ,pp. : 267-272

Elsevier

Access to resources Recommend Favorite

Ocular actions of platelet-activating factor: clinical implications

By Nitoda Eirini   Moschos Marilita M   Mavragani Clio P   Koutsilieris Michael  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 10, 2012-10 ,pp. : 1027-1039

Informa Healthcare

Access to resources Recommend Favorite

Current status of platelet-activating factor antagonists

By Curtin M.L.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 6, 1998-06 ,pp. : 703-711

Informa Healthcare

Access to resources Recommend Favorite

Pharmacology of ABT-491, a highly potent platelet-activating factor receptor antagonist

By Albert D.H.   Magoc T.J.   Tapang P.   Luo G.   Morgan D.W.   Curtin M.   Sheppard G.S.   Xu L.   Heyman H.R.   Davidsen S.K.   Summers J.B.   Carter G.W.  

European Journal of Pharmacology, Vol. 325, Iss. 1, 1997-04 ,pp. : 69-80

Elsevier

Access to resources Recommend Favorite

Effects of liposome-entrapped platelet-activating factor in the isolated rat trachea

By Costuleanu M.   Brailoiu E.   Filipeanu C.M.   Baltatu O.   Slatineanu S.   Saila L.   Nechifor M.   Branisteanu D.D.  

European Journal of Pharmacology, Vol. 281, Iss. 1, 1995-07 ,pp. : 89-92

Elsevier

Access to resources Recommend Favorite